Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 5/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22164705 | 0.99 | ALDH1A1 (0.39) | ALDH1A1KMT2AMAPTHSD17B10HPGD | |
| SCHEMBL23967385 | 0.91 | PTPN1 (0.38) | ALDH1A1KMT2ALMNATSHRMAPK1 | |
| SCHEMBL22165526 | 0.89 | PTPN1 (0.35) | ALDH1A1KMT2ALMNATSHRMAPK1 | |
| SCHEMBL23967368 | 0.89 | PTPN1 (0.35) | ALDH1A1KMT2ALMNATSHRMAPK1 | |
| SCHEMBL22165524 | 0.88 | MTNR1A (0.38) | ALDH1A1KMT2AMAPTHSD17B10LMNA | |
| SCHEMBL23967364 | 0.88 | ALDH1A1 (0.38) | ALDH1A1KMT2AMAPTHSD17B10LMNA | |
| SCHEMBL23967393 | 0.87 | ABCB1 (0.45) | ALDH1A1KMT2AMAPTHSD17B10LMNA | |
| SCHEMBL22164729 | 0.85 | LMNA (0.34) | ALDH1A1KMT2AMAPTLMNATSHR | |
| SCHEMBL22165407 | 0.85 | MAPT (0.36) | ALDH1A1KMT2AMAPTLMNATSHR | |
| SCHEMBL22173784 | 0.83 | ALDH1A1 (0.37) | ALDH1A1KMT2AMAPTHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12139491-B2 | Diketopiperazine derivatives as calcium ATPase inhibitor for enhancing anticancer activity | HOLOSMEDIC (KR) | 2024-11-12 | — | — | US | disclosed |
| WO-2021261969-A1 | PREPARATION METHOD FOR NOVEL COMPOUND | 홀로스메딕 주식회사 | 2021-12-30 | — | — | WO | disclosed |
| EP-3903786-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR ENHANCING ANTICANCER ACTIVITY | Holosmedic (KR) | 2021-11-03 | — | — | EP | disclosed |
| EP-3903786-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR ENHANCING ANTICANCER ACTIVITY | Holosmedic (KR) | 2021-11-03 | — | — | EP | disclosed |
| CN-113260365-A | Novel compound and pharmaceutical composition for enhancing anticancer activity comprising the same | 治愈医药社株式会社 | 2021-08-13 | — | — | CN | disclosed |
| WO-2020139044-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR ENHANCING ANTICANCER ACTIVITY | 홀로스메딕 주식회사 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020139044-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR ENHANCING ANTICANCER ACTIVITY | 홀로스메딕 주식회사 | 2020-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12139491-B2 | Diketopiperazine derivatives as calcium ATPase inhibitor for enhancing anticancer activity | ATP1A1, ATP1B1, ATP1B2 | ALDH1A1 2883/4885KMT2A 3082/4885MAPT 3132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.